IDBS

IDBS announces data management partnership with PharmaEssentia Innovation Research Center

Retrieved on: 
Tuesday, January 23, 2024

WOKING, England, Jan. 23, 2024 /PRNewswire/ -- IDBS announced today that it has entered into a partnership with Massachusetts-based PharmaEssentia Innovation Research Center (PIRC) on its Polar platform to help digitize data management and facilitate collaboration between the company's global research and development (R&D) teams.

Key Points: 
  • WOKING, England, Jan. 23, 2024 /PRNewswire/ -- IDBS announced today that it has entered into a partnership with Massachusetts-based PharmaEssentia Innovation Research Center (PIRC) on its Polar platform to help digitize data management and facilitate collaboration between the company's global research and development (R&D) teams.
  • IDBS helps BioPharmaceutical organizations accelerate the discovery, development and manufacturing of the next generation of life-changing therapies that advance human health worldwide.
  • Known for its signature IDBS E-WorkBook product, IDBS has extended solutions across the entire value chain for BioPharma Lifecycle Management (BPLM) .
  • Built on analytics-centric and cloud-native technology, IDBS Polar and IDBS PIMS platforms are powered by a digital data backbone to drive faster and smarter decisions in drug development and across the supply chain.

New process definition capabilities in PIMS further enhance quality assurance and "right -first-time" initiatives for pharma manufacturers

Retrieved on: 
Tuesday, November 28, 2023

WOKING, England, Nov. 28, 2023 /PRNewswire/ -- IDBS unveils new process definition templates in its latest release, PIMS 5.1.

Key Points: 
  • WOKING, England, Nov. 28, 2023 /PRNewswire/ -- IDBS unveils new process definition templates in its latest release, PIMS 5.1.
  • Process definition templates enable pharma manufacturers to template process steps and quality specifications for faster process definition set-up and improved harmonization across the manufacturing teams to further enhance quality assurance (QA) and "right-first-time" initiatives.
  • This release builds on recent PIMS' process definition enhancements that added process definition versioning and approvals to help alleviate manual standard operating procedure (SOP) requirements and enhance QA for a more robust GxP environment.
  • PIMS' customers report that these standardized process definition templates will reduce their manual process definition set-up and enable easy, harmonized site and product comparisons.

New process definition capabilities in PIMS further enhance quality assurance and "right -first-time" initiatives for pharma manufacturers

Retrieved on: 
Tuesday, November 28, 2023

WOKING, England, Nov. 28, 2023 /PRNewswire/ -- IDBS unveils new process definition templates in its latest release, PIMS 5.1.

Key Points: 
  • WOKING, England, Nov. 28, 2023 /PRNewswire/ -- IDBS unveils new process definition templates in its latest release, PIMS 5.1.
  • Process definition templates enable pharma manufacturers to template process steps and quality specifications for faster process definition set-up and improved harmonization across the manufacturing teams to further enhance quality assurance (QA) and "right-first-time" initiatives.
  • This release builds on recent PIMS' process definition enhancements that added process definition versioning and approvals to help alleviate manual standard operating procedure (SOP) requirements and enhance QA for a more robust GxP environment.
  • PIMS' customers report that these standardized process definition templates will reduce their manual process definition set-up and enable easy, harmonized site and product comparisons.

New process definition capabilities in PIMS enhance quality assurance and validation for pharma manufacturers

Retrieved on: 
Tuesday, May 2, 2023

Providing contextualized access to aggregated manufacturing data, PIMS offers a single source of data truth for efficient gathering, sharing and analysis of critical manufacturing process and quality data to support Continued Process Verification (CPV), investigations and process optimization.

Key Points: 
  • Providing contextualized access to aggregated manufacturing data, PIMS offers a single source of data truth for efficient gathering, sharing and analysis of critical manufacturing process and quality data to support Continued Process Verification (CPV), investigations and process optimization.
  • PIMS' process definition capabilities already allow pharma manufacturers to view their processes with their specific parameters for all major process steps and across manufacturing batches.
  • This latest release adds process definition versioning and approvals to help alleviate manual Standard Operating Procedure (SOP) requirements and enhance quality assurance (QA).
  • "Having their critical process data in PIMS already gives them the assurance of data integrity and these new enhancements now make it even easier to complete QA and validation steps."

New process definition capabilities in PIMS enhance quality assurance and validation for pharma manufacturers

Retrieved on: 
Tuesday, May 2, 2023

Providing contextualized access to aggregated manufacturing data, PIMS offers a single source of data truth for efficient gathering, sharing and analysis of critical manufacturing process and quality data to support Continued Process Verification (CPV), investigations and process optimization.

Key Points: 
  • Providing contextualized access to aggregated manufacturing data, PIMS offers a single source of data truth for efficient gathering, sharing and analysis of critical manufacturing process and quality data to support Continued Process Verification (CPV), investigations and process optimization.
  • PIMS' process definition capabilities already allow pharma manufacturers to view their processes with their specific parameters for all major process steps and across manufacturing batches.
  • This latest release adds process definition versioning and approvals to help alleviate manual Standard Operating Procedure (SOP) requirements and enhance quality assurance (QA).
  • "Having their critical process data in PIMS already gives them the assurance of data integrity and these new enhancements now make it even easier to complete QA and validation steps."

IDBS Appoints New General Manager

Retrieved on: 
Monday, April 24, 2023

WOKING, England, April 24, 2023 /PRNewswire/ -- IDBS has appointed Pietro Forgione as its new General Manager.

Key Points: 
  • WOKING, England, April 24, 2023 /PRNewswire/ -- IDBS has appointed Pietro Forgione as its new General Manager.
  • Pietro has spent the last 16 years at IDBS with responsibilities for EMEA sales, Global Key Accounts, and most recently, as Vice President of Product, Strategy and Marketing.
  • In this role, he was instrumental in defining IDBS' strategy and competitive positioning, working with the teams designing and launching Polar as its category-defining BioPharma Lifecycle Management offering.
  • IDBS has more than 35 years of experience in helping solve some of the most complex workflow and data challenges across the BioPharmaceutical lifecycle.

IDBS Appoints New General Manager

Retrieved on: 
Monday, April 24, 2023

WOKING, England, April 24, 2023 /PRNewswire/ -- IDBS has appointed Pietro Forgione as its new General Manager.

Key Points: 
  • WOKING, England, April 24, 2023 /PRNewswire/ -- IDBS has appointed Pietro Forgione as its new General Manager.
  • Pietro has spent the last 16 years at IDBS with responsibilities for EMEA sales, Global Key Accounts, and most recently, as Vice President of Product, Strategy and Marketing.
  • In this role, he was instrumental in defining IDBS' strategy and competitive positioning, working with the teams designing and launching Polar as its category-defining BioPharma Lifecycle Management offering.
  • IDBS has more than 35 years of experience in helping solve some of the most complex workflow and data challenges across the BioPharmaceutical lifecycle.

IDBS and SciBite bring enterprise ontologies and scientific data management together through a new partnership to unlock value from data through improved interoperability

Retrieved on: 
Wednesday, March 1, 2023

SciBite is leading the way in supporting the transition from an "application-centric" to a "data-centric" approach to FAIR.

Key Points: 
  • SciBite is leading the way in supporting the transition from an "application-centric" to a "data-centric" approach to FAIR.
  • Through this partnership, IDBS and SciBite aim to empower customers to achieve "data-centric" FAIR, aligning data to a set of centralized standards, improving interoperability and unlocking untapped value in our customers' data.
  • This ensures that customers benefit from higher data interoperability and more consistent master data management (MDM).
  • This connector is the first step in our partnership with SciBite to empower customers to unlock value from their data to accelerate scientific discovery and development," said Christian Marcazzo, Vice President and General Manager at IDBS.

IDBS and SciBite bring enterprise ontologies and scientific data management together through a new partnership to unlock value from data through improved interoperability

Retrieved on: 
Wednesday, March 1, 2023

SciBite is leading the way in supporting the transition from an "application-centric" to a "data-centric" approach to FAIR.

Key Points: 
  • SciBite is leading the way in supporting the transition from an "application-centric" to a "data-centric" approach to FAIR.
  • Through this partnership, IDBS and SciBite aim to empower customers to achieve "data-centric" FAIR, aligning data to a set of centralized standards, improving interoperability and unlocking untapped value in our customers' data.
  • This ensures that customers benefit from higher data interoperability and more consistent master data management (MDM).
  • This connector is the first step in our partnership with SciBite to empower customers to unlock value from their data to accelerate scientific discovery and development," said Christian Marcazzo, Vice President and General Manager at IDBS.

New IDBS Polar data science capabilities democratize access to AI/ML-powered insights to accelerate BioPharma process optimization

Retrieved on: 
Thursday, February 23, 2023

WOKING, United Kingdom, Feb. 23, 2023 /PRNewswire/ -- IDBS announces the launch of new data science capabilities for its Polar platform to accelerate BioPharma process optimization.

Key Points: 
  • WOKING, United Kingdom, Feb. 23, 2023 /PRNewswire/ -- IDBS announces the launch of new data science capabilities for its Polar platform to accelerate BioPharma process optimization.
  • Accessing meaningful insights from process and quality data across the BioPharmaceutical lifecycle is critical to accelerating time to market of life-changing therapies.
  • IDBS Polar unlocks the value of data by providing integrated digital workflows, eliminating data silos and delivering a high-quality, contextualized data backbone.
  • Democratizing access to process insight enables BioPharma organizations to efficiently focus resources on the critical areas for quality and performance to accelerate process development, regulatory filings and technology transfer."